Kane BiotechKNBIF +5.19% Days Payable is 1,347.28 as of Mar. 2026, which is 381% above its 10-year median of 280.24. The stock has 6 warning signs investors should review. Among 708 Biotechnology companies, Kane Biotech ranks better than 92.23% on this metric.
The historical rank and industry rank for Kane Biotech's Days Payable or its related term are showing as below:
KNBIF'
s Days Payable Range Over the Past 10 Years
Min: 136.02 Med: 280.24 Max: 4984.28
Current: 3368.43
During the past 13 years, Kane Biotech's highest Days Payable was 4984.28. The lowest was 136.02. And the median was 280.24.
KNBIF's Days Payable is ranked better than 92.23% of 708
companies
in the Biotechnology industry
Industry Median: 113.56
vs KNBIF: 3368.43
Kane Biotech's Days Payable
increased
from Mar. 2025 (264.24) to Mar. 2026 (1,347.28).
It may suggest that Kane Biotechdelayed paying its suppliers.
Kane Biotech Days Payable Related Terms
Kane Biotech Days Payable Historical Data
* Premium members only.
The historical data trend for Kane Biotech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KNBIF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Kane Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kane Biotech Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kane Biotech's Days Payable distribution charts can be found below:
* The bar in red indicates where Kane Biotech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kane Biotech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kane Biotech (KNBIF) has a Days Payable of 1,347.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kane Biotech and its competitors. This is 381% above median its historical median of 280.24. Over the past decade, Kane Biotech's Days Payable has ranged from 136.02 to 4,984.28. According to the industry distribution chart, Kane Biotech ranks #55 out of 708 companies in the Biotechnology industry, placing it in the top 7.8%.
Is Kane Biotech's Days Payable too high?
Kane Biotech's current Days Payable of 1,347.28 is 381% above median its 10-year median of 280.24. Over the past 10 years, this metric has ranged from a low of 136.02 to a high of 4,984.28. The Biotechnology industry median Days Payable is 113.56. Kane Biotech's value of 1,347.28 is 1086.4% above this industry median. Based on the distribution chart, Kane Biotech ranks #55 out of 708 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Kane Biotech's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #55 out of 708 companies for Days Payable. This places Kane Biotech in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Kane Biotech's value of 1,347.28 is 1086.4% above this benchmark. Historically, Kane Biotech's own Days Payable has ranged from 136.02 to 4,984.28 over the past decade. While the company's 10-year median is 280.24 vs. the industry median of 113.56, Kane Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kane Biotech's current Days Payable of 1,347.28 is 1086.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kane Biotech and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kane Biotech's current Days Payable is 1,347.28, which is 381% above median its own 10-year median of 280.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Days Payable of 1,347.28. The current Days Payable is 1,347.28, which is 381% above median its 10-year median of 280.24 and 1086.4% above the Biotechnology industry median of 113.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Days Payable is 1,347.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KNBIF has been successfully added to your 